Catalyst Wire Dossier Catalyst Wire Dossier

EXTREME regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EXTREME regimen, covering 2019-12-20 to 2019-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) [Phase 3]

See pricing